FDA CATALYST CALENDAR - 2025

Key PDUFA Dates and Catalysts:

Q2 2025:
- Apr 15: LLY - Donanemab (Alzheimer's)
- May 20: ABBV - Epcoritamab (Lymphoma)
- Jun 30: REGN - Dupixent (COPD expansion)

Q3 2025:
- Jul 15: BMY - Repotrectinib (Lung cancer)
- Aug 22: MRK - V116 (Pneumococcal)
- Sep 10: PFE - Elrexfio (Myeloma)

Q4 2025:
- Oct 5: AMGN - Tarlatamab (Lung cancer)
- Nov 15: GILD - Lenacapavir (HIV prevention)
- Dec 20: NVO - Oral Semaglutide 2.0

Advisory Committee Meetings:
- Apr 8: FDA AdCom - Gene therapy safety
- Jun 12: FDA AdCom - AI in drug development
